Illness	Number of cases
Non-follicular lymphoma (C83.3)	431
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	214
Malignant neoplasm of eye and adnexa (C69.3)	178
Myeloid leukaemia - Acute myeloblastic leukemia not having achieved remission (C92.00)	108
Malignant neoplasm of prostate (C61)	71
Malignant neoplasm of testis (C62.1)	63
Secondary malignant neoplasm of respiratory and digestive organs - Secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7)	61
Malignant neoplasm without specification of site - Disseminated malignant neoplasm unspecified (C80.0)	42
Hodgkin lymphoma (C81.1)	41
Other and unspecified infectious diseases (B99)	34

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	894
Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.91)	400
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	375
Treatment procedure to maintain and encourage practical everyday and social skills - psychosocial intervention (9-401.30)	329
Taking a tissue sample (biopsy) of the bone marrow without surgical incision (1-424)	305
Cancer treatment for several days (e.g. 5-8 days) with two or more chemotherapy drugs administered into a vein (8-544)	304
Administration of medicines in accordance with List 2 of the procedures list (6-002.72)	282
Others therapeutic procedures to influence the immune system (8-547.1)	281
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	266
(9-984.7)	234

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500 , 3752

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Brustkrebs

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ08
CQ05
CQ02
CQ03
CQ24
CQ25
CQ26
CQ27

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
1.922	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
137	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
131	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	als Universitätsmedizin hat die Charité eigene Professuren sowie Dozierende und Lehrbeauftragte
Student training (clinical traineeship / internship year)	die vollständige Studierendenausbildung in den grundständigen Studiengängen Medizin (als Modell), Zahnmedizin und Gesundheitswissenschaften (Bachelor)/Health Professions Education (Master), Public Health (Master), Pflegewissenschaft (Bachelor) und Angewandte Hebammenwissenschaft wird durchgeführt
Project-related cooperation with colleges and universities	die Charité führt eine Vielzahl projektbezogener Kooperationen mit anderen Universitäten, Hochschulen und außeruniversitären Forschungseinrichtungen durch
Participation in multi-centre Phase I/II studies	die Charité führt eine Vielzahl entsprechender Studien durch
Participation in multi-centre phase III/IV studies	die Charité führt eine Vielzahl entsprechender Studien durch
Initiation and management of uni-centric/multi-centric clinical/scientific studies	die Charité führt eine Vielzahl selbst von Wissenschaftler:innen der Charité eigeninitiierter Studien durch, dazu existieren u.a. zentrale Unterstützungsstrukturen, wie das Clinical Trial Office (CTO) und die QA-Unit Klinische Studien
Editors of scientific journals/textbooks	Wissenschaftler/innen der Charité sind an einer Vielzahl wissenschaftlicher Journale in den Editorial Boards beteiligt. Wichtige Lehrbücher der Biomedizin beinhalten umfassende Beiträge aus der Charité
Doctoral supervision	die Charité hat als universitäre Einrichtung das Promotionsrecht und vergibt den Dr. med, den Dr. med. dent, den Dr. rer. medic. sowie einen PhD

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB02	Health and paediatric nurse (m/f)
HB03	Physical therapist / physiotherapist (m/f)
HB07	Surgical technical assistant (m/f)
HB09	Speech therapist (m/f)
HB10	Midwife (m/f)	Die Hebammenausbildung ist seit dem WS 2021/2022 akademisiert und läuft als Ausbildung in Heilberufen aus.
HB16	Dietician (m/f)